| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF704 HOXC13 MZF1 FOXN4 GLI2 GLI4 GATA2 GATA3 SP6 DMRTC2 POU3F3 MLXIP SNAPC4 RFX7 NEUROD6 LEF1 | 5.09e-06 | 1271 | 69 | 16 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF704 HOXC13 MZF1 GLI2 GLI4 GATA2 GATA3 SP6 DMRTC2 POU3F3 MLXIP SNAPC4 RFX7 NEUROD6 LEF1 | 1.78e-05 | 1244 | 69 | 15 | GO:0000978 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | HOXC13 MZF1 FOXN4 GLI2 GLI4 GATA2 GATA3 SP6 DMRTC2 PLAGL2 POU3F3 MLXIP RFX7 NEUROD6 LEF1 | 7.68e-05 | 1412 | 69 | 15 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF704 HOXC13 MZF1 GLI2 GLI4 GATA2 GATA3 SP6 DMRTC2 POU3F3 MLXIP SNAPC4 RFX7 NEUROD6 LEF1 | 1.11e-04 | 1459 | 69 | 15 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.28e-04 | 560 | 69 | 9 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.38e-04 | 566 | 69 | 9 | GO:0001216 | |
| GeneOntologyMolecularFunction | gamma-catenin binding | 7.60e-04 | 12 | 69 | 2 | GO:0045295 | |
| GeneOntologyMolecularFunction | C2H2 zinc finger domain binding | 1.55e-03 | 17 | 69 | 2 | GO:0070742 | |
| GeneOntologyBiologicalProcess | ventral spinal cord interneuron differentiation | 1.27e-05 | 14 | 69 | 3 | GO:0021514 | |
| GeneOntologyBiologicalProcess | central nervous system development | NCOR2 ARHGEF28 IL1RAPL2 FOXN4 GLI2 GATA2 MAST1 POU3F3 TMEM108 CPLANE1 NEUROD6 LEF1 PCDH9 RECK | 3.49e-05 | 1197 | 69 | 14 | GO:0007417 |
| GeneOntologyCellularComponent | chromatin | NCOR2 FAM111A HOXC13 VPS72 FOXN4 ZMIZ2 MORF4L1 GATA3 SP6 DMRTC2 POU3F3 MLXIP RFX7 NEUROD6 LEF1 | 5.44e-05 | 1480 | 67 | 15 | GO:0000785 |
| MousePheno | abnormal temporomandibular joint morphology | 3.36e-06 | 8 | 56 | 3 | MP:0011210 | |
| MousePheno | abnormal hair cuticle | 3.98e-05 | 17 | 56 | 3 | MP:0003810 | |
| MousePheno | absent temporomandibular joint | 4.72e-05 | 3 | 56 | 2 | MP:0030111 | |
| Domain | TF_GATA-2/3 | 3.79e-05 | 3 | 67 | 2 | IPR016374 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | HOXC13 MZF1 FOXN4 GLI2 GATA2 GATA3 SP6 DMRTC2 PLAGL2 POU3F3 TSC22D2 MLXIP SNAPC4 RFX7 NEUROD6 LEF1 | 3.42e-11 | 908 | 71 | 16 | 19274049 |
| Pubmed | GDE2 promotes neurogenesis by glycosylphosphatidylinositol-anchor cleavage of RECK. | 9.68e-07 | 10 | 71 | 3 | 23329048 | |
| Pubmed | 1.75e-06 | 709 | 71 | 10 | 22988430 | ||
| Pubmed | 1.77e-06 | 12 | 71 | 3 | 16020526 | ||
| Pubmed | 2.30e-06 | 13 | 71 | 3 | 25369423 | ||
| Pubmed | 2.70e-06 | 191 | 71 | 6 | 24146773 | ||
| Pubmed | Notch and MAML signaling drives Scl-dependent interneuron diversity in the spinal cord. | 2.92e-06 | 14 | 71 | 3 | 17359917 | |
| Pubmed | ZNF503/Zpo2 drives aggressive breast cancer progression by down-regulation of GATA3 expression. | 4.11e-06 | 2 | 71 | 2 | 28258171 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 15328158 | ||
| Pubmed | GATA motifs regulate early hematopoietic lineage-specific expression of the Gata2 gene. | 4.11e-06 | 2 | 71 | 2 | 16055713 | |
| Pubmed | ZNF503 combined with GATA3 is a prognostic factor in triple-negative breast cancer. | 4.11e-06 | 2 | 71 | 2 | 37036735 | |
| Pubmed | Lymphoid enhancer factor interacts with GATA-3 and controls its function in T helper type 2 cells. | 4.11e-06 | 2 | 71 | 2 | 18445004 | |
| Pubmed | GATA2-dependent and region-specific regulation of Gata2 transcription in the mouse midbrain. | 4.11e-06 | 2 | 71 | 2 | 19371385 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 7720565 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 38346193 | ||
| Pubmed | The essential role of GATA transcription factors in adult murine prostate. | 4.11e-06 | 2 | 71 | 2 | 27374105 | |
| Pubmed | GATA3 is downregulated during hair cell differentiation in the mouse cochlea. | 4.11e-06 | 2 | 71 | 2 | 10447238 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 19106099 | ||
| Pubmed | Smad4-dependent desmoglein-4 expression contributes to hair follicle integrity. | 5.43e-06 | 17 | 71 | 3 | 18692037 | |
| Pubmed | NCOR2 VPS72 GLI2 ZMIZ2 MORF4L1 GATA2 GATA3 FBRSL1 PSMD4 RFX7 LRIF1 ZNF503 STAU1 | 5.68e-06 | 1429 | 71 | 13 | 35140242 | |
| Pubmed | Dlx3 is a crucial regulator of hair follicle differentiation and cycling. | 6.51e-06 | 18 | 71 | 3 | 18684741 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 7.68e-06 | 351 | 71 | 7 | 38297188 | |
| Pubmed | Ascl1 Balances Neuronal versus Ependymal Fate in the Spinal Cord Central Canal. | 7.72e-06 | 19 | 71 | 3 | 31461644 | |
| Pubmed | 7.72e-06 | 19 | 71 | 3 | 16319112 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | LIMK1 ARHGEF28 HIPK4 SIPA1L1 SIK1 PLEKHG2 MLXIP RFX7 EPB41L1 ANKS1A | 9.69e-06 | 861 | 71 | 10 | 36931259 |
| Pubmed | LIMK1 VPS72 MICAL2 SIPA1L1 MORF4L1 MAST1 PSMD4 LRBA AMOTL2 NEUROD6 VARS1 RECK | 1.05e-05 | 1285 | 71 | 12 | 35914814 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | NCOR2 HOXC13 MZF1 GATA2 GATA3 DMRTC2 PLAGL2 MLXIP SNAPC4 LEF1 | 1.14e-05 | 877 | 71 | 10 | 20211142 |
| Pubmed | Conserved and Divergent Molecular and Anatomic Features of Human and Mouse Nephron Patterning. | 1.22e-05 | 22 | 71 | 3 | 29449451 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 12041667 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 27528231 | ||
| Pubmed | GATA-1, -2 and -3 genes expression in bone marrow microenviroment with chronic aplastic anemia. | 1.23e-05 | 3 | 71 | 2 | 17654061 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 36806146 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 28232602 | ||
| Pubmed | Repression via the GATA box is essential for tissue-specific erythropoietin gene expression. | 1.23e-05 | 3 | 71 | 2 | 18202227 | |
| Pubmed | Dynamic regulation of Gata factor levels is more important than their identity. | 1.23e-05 | 3 | 71 | 2 | 17327407 | |
| Pubmed | Tbx2 and Tbx3 regulate cell fate progression of the otic vesicle for inner ear development. | 1.40e-05 | 23 | 71 | 3 | 36521641 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NCOR2 ZMIZ2 GATA2 FBRSL1 ITGA3 LRBA MLXIP SNAPC4 DHX34 ZNF503 BAHCC1 | 1.42e-05 | 1105 | 71 | 11 | 35748872 |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 1.53e-05 | 544 | 71 | 8 | 28473536 | |
| Pubmed | 1.54e-05 | 152 | 71 | 5 | 38360978 | ||
| Pubmed | GATA-2 and GATA-3 regulate trophoblast-specific gene expression in vivo. | 2.46e-05 | 4 | 71 | 2 | 9043071 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 15542836 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 18849568 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 32562431 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 29091766 | ||
| Pubmed | The murine placenta contains hematopoietic stem cells within the vascular labyrinth region. | 2.46e-05 | 4 | 71 | 2 | 15737933 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 15632071 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 18077697 | ||
| Pubmed | The transcription factor GATA3 is a downstream effector of Hoxb1 specification in rhombomere 4. | 2.46e-05 | 4 | 71 | 2 | 10556076 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | NCOR2 FAM111A DSG1 MICAL2 GLI2 GLI4 MORF4L1 GATA3 PSMD4 POU3F3 ITGA3 | 3.10e-05 | 1203 | 71 | 11 | 29180619 |
| Pubmed | iRhom2 mutation leads to aberrant hair follicle differentiation in mice. | 3.18e-05 | 30 | 71 | 3 | 25546423 | |
| Pubmed | c-Jun is required for the specification of joint cell fates. | 3.52e-05 | 31 | 71 | 3 | 23475960 | |
| Pubmed | Sox11 gene disruption causes congenital anomalies of the kidney and urinary tract (CAKUT). | 3.52e-05 | 31 | 71 | 3 | 29459093 | |
| Pubmed | The late and dual origin of cerebrospinal fluid-contacting neurons in the mouse spinal cord. | 3.52e-05 | 31 | 71 | 3 | 26839365 | |
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 20705609 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 37386251 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 15016828 | ||
| Pubmed | Normal reproductive and macrophage function in Pem homeobox gene-deficient mice. | 4.09e-05 | 5 | 71 | 2 | 9769172 | |
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 22493062 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 1744088 | ||
| Pubmed | Palmitoylation regulates epidermal homeostasis and hair follicle differentiation. | 4.66e-05 | 34 | 71 | 3 | 19956733 | |
| Pubmed | Coexpression of SCL and GATA3 in the V2 interneurons of the developing mouse spinal cord. | 6.13e-05 | 6 | 71 | 2 | 12112475 | |
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 24785493 | ||
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 31619968 | ||
| Pubmed | Gata2 specifies serotonergic neurons downstream of sonic hedgehog. | 6.13e-05 | 6 | 71 | 2 | 14973276 | |
| Pubmed | Phosphorylation of microtubule-associated protein tau by AMPK-related kinases. | 6.13e-05 | 6 | 71 | 2 | 21985311 | |
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 10364157 | ||
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 23732910 | ||
| Pubmed | The Fgf9-Nolz1-Wnt2 axis regulates morphogenesis of the lung. | 6.53e-05 | 38 | 71 | 3 | 37497597 | |
| Pubmed | 7.63e-05 | 40 | 71 | 3 | 17199044 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 11724781 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 23595732 | ||
| Pubmed | Partially overlapping expression of Gata2 and Gata3 during inner ear development. | 8.57e-05 | 7 | 71 | 2 | 15499560 | |
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 21529783 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 16678815 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 18212046 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 2850480 | ||
| Pubmed | 8.84e-05 | 42 | 71 | 3 | 23863479 | ||
| Pubmed | 9.49e-05 | 43 | 71 | 3 | 11827452 | ||
| Pubmed | The WNT7A/WNT7B/GPR124/RECK signaling module plays an essential role in mammalian limb development. | 1.14e-04 | 8 | 71 | 2 | 35552394 | |
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 18218781 | ||
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 17011173 | ||
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 28369467 | ||
| Pubmed | Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. | 1.14e-04 | 8 | 71 | 2 | 17187062 | |
| Pubmed | Gata6 restricts Isl1 to the posterior of nascent hindlimb buds through Isl1 cis-regulatory modules. | 1.14e-04 | 8 | 71 | 2 | 29197504 | |
| Pubmed | 1.24e-04 | 47 | 71 | 3 | 28219675 | ||
| Pubmed | A Cre transgenic line for studying V2 neuronal lineages and functions in the spinal cord. | 1.47e-04 | 9 | 71 | 2 | 20806357 | |
| Pubmed | Role of Phox2b and Mash1 in the generation of the vestibular efferent nucleus. | 1.47e-04 | 9 | 71 | 2 | 12885554 | |
| Pubmed | MACF1 regulates the migration of pyramidal neurons via microtubule dynamics and GSK-3 signaling. | 1.47e-04 | 9 | 71 | 2 | 25224226 | |
| Pubmed | 1.47e-04 | 9 | 71 | 2 | 21523854 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.65e-04 | 398 | 71 | 6 | 35016035 | |
| Pubmed | 1.83e-04 | 10 | 71 | 2 | 10707971 | ||
| Pubmed | 1.83e-04 | 10 | 71 | 2 | 18156176 | ||
| Pubmed | 1.83e-04 | 10 | 71 | 2 | 17728344 | ||
| Pubmed | 1.83e-04 | 10 | 71 | 2 | 14715945 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF704 NCOR2 FAM111A MICAL2 GLI2 FBRSL1 MAST1 LRBA RECK EPB41L1 ANKS1A | 2.06e-04 | 1489 | 71 | 11 | 28611215 |
| Pubmed | 2.09e-04 | 56 | 71 | 3 | 33053343 | ||
| Pubmed | Essential role of Gata transcription factors in sympathetic neuron development. | 2.23e-04 | 11 | 71 | 2 | 15329349 | |
| Pubmed | 2.23e-04 | 11 | 71 | 2 | 16365040 | ||
| Pubmed | 2.23e-04 | 11 | 71 | 2 | 10357893 | ||
| Pubmed | The Shh signalling pathway in tooth development: defects in Gli2 and Gli3 mutants. | 2.23e-04 | 11 | 71 | 2 | 9655803 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 5.96e-04 | 15 | 44 | 2 | 82 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | ZNF704 CSPG5 MORF4L1 GATA2 GATA3 SP6 PLAGL2 RFX7 LEF1 BAHCC1 | 5.12e-07 | 467 | 71 | 10 | M1347 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | ZNF704 CSPG5 MORF4L1 GATA2 GATA3 SP6 PLAGL2 RFX7 LEF1 BAHCC1 | 7.08e-07 | 484 | 71 | 10 | MM999 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL | NYAP2 ARHGEF28 SH2D3C GATA3 MAST1 TMEM108 BRSK1 EPB41L1 ANKS1A | 7.78e-07 | 375 | 71 | 9 | M45799 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.93e-06 | 148 | 71 | 5 | 9fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Endothelial-endothelial_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-06 | 173 | 71 | 5 | 2a5ea28c65dd4ee03ba3d0bfe0c819b1d583f8da | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Endothelial|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-06 | 173 | 71 | 5 | 6a7e4fa2d9d00f50decc89b535d8a68ec96de58a | |
| ToppCell | droplet-Heart-nan-24m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 181 | 71 | 5 | 859c40889ede2cbf374c4d2efbb72dc3bc6441f5 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.10e-05 | 183 | 71 | 5 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 1.10e-05 | 183 | 71 | 5 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.19e-05 | 186 | 71 | 5 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-05 | 188 | 71 | 5 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.32e-05 | 190 | 71 | 5 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 193 | 71 | 5 | e4b440d50ae7391b26924778be6d9d53e0692449 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 193 | 71 | 5 | e523dc5751f6fdcd4fc1a62b1eecd43f6ae79da9 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 193 | 71 | 5 | 1772f2ac217727de63c4a9303881b3a19a6bb0f0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 196 | 71 | 5 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.69e-05 | 200 | 71 | 5 | 9cff8be6e566f342fc8b45e93106d033b14759ee | |
| ToppCell | TCGA-Liver-Primary_Tumor|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.69e-05 | 200 | 71 | 5 | b667168081393433597f6ca8baeddba1d1906d40 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Interneuron|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.69e-05 | 200 | 71 | 5 | 08bee924a2654e05df3b39e8a51f93c8b3472175 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-05 | 121 | 71 | 4 | a5962d1c476e6966870832b72d511607e047248b | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.57e-05 | 130 | 71 | 4 | c70fb77324916d220d842a575558a8245c276599 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.63e-05 | 141 | 71 | 4 | e409da87da5a38ba4d0ccc5e3f8bd89f480f9dab | |
| ToppCell | LPS-IL1RA-Hematopoietic_Mast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.84e-05 | 142 | 71 | 4 | f7d0d5ca9fc3dd929d4fdd59b71bfa623007e992 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Mast-Mast_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.84e-05 | 142 | 71 | 4 | 2a9a070e7c53ac593d46c6c5f6983f07d4413501 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-04 | 153 | 71 | 4 | ee6f4770c6e35d59bdeec5b0ecb10119fa8c3ca5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-04 | 153 | 71 | 4 | a35149a0c8b4ec9ad27cc4b3d34fba3b8714a6a2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-04 | 153 | 71 | 4 | 90cd6efda83c0b4b80eae2c90e7ff45dfd936dc2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 155 | 71 | 4 | 8b524c65fa5c901f70c7caae4ec7fd2859eaf227 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 155 | 71 | 4 | 72a19a9ecfd13f6769c4b447d3ce01a855ec6ec7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 155 | 71 | 4 | 7fe8b8c0c8a9e3190cfd52d3934509e6780e1717 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-04 | 159 | 71 | 4 | f7bccfeffa737f151417bf52ea45111b0957bce9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.24e-04 | 160 | 71 | 4 | 70f3637dd0bcfcef421aa114f946fff0048f192e | |
| ToppCell | BL-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.30e-04 | 162 | 71 | 4 | 25ec9df914445b4daae4fd28fd0e60b64797c46d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-04 | 164 | 71 | 4 | dd29decc6c41a580cfdf03962827ec18d432935f | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-04 | 164 | 71 | 4 | dcd3c3ee73900180451fad9b4de0efedbd375e1c | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.53e-04 | 169 | 71 | 4 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | NS-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.57e-04 | 170 | 71 | 4 | f6a0162bb690dbc19ff1cec64cb933744ad3b496 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-04 | 170 | 71 | 4 | 4cd3b7e43a061948084c01713ae141b5c2c07d89 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Endothelial-new-cluster|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 170 | 71 | 4 | 4fb4ce46e4fa2418238e264875209d7ebe844d82 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-04 | 170 | 71 | 4 | 36c9f7f98612a72dc511c8da4358d67444f6bcf4 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.57e-04 | 170 | 71 | 4 | 8e9b5f7bfb61f8d84d0b17fb0c191da4dabad63d | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-04 | 174 | 71 | 4 | 58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-04 | 175 | 71 | 4 | 2a53d4f140d5ab096efe8118d8aa351db7838b49 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-04 | 175 | 71 | 4 | fb91a45763e4c48d993094a13088ffc19f1e2574 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-04 | 175 | 71 | 4 | f949613ee45f5d950578c512d197716855118d18 | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.87e-04 | 178 | 71 | 4 | 8bae5db100f4563aa1fc7f881e7f8c59d669e37a | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.87e-04 | 178 | 71 | 4 | bc0336692b84bd0fa49747ed5a031b8ed8afa0fd | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 179 | 71 | 4 | 88dbec952507d84b85b08165eec80df99ed1e736 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 179 | 71 | 4 | daf8189a22786171e2b629261cf720736aa4ebdb | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 1.91e-04 | 179 | 71 | 4 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.91e-04 | 179 | 71 | 4 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.91e-04 | 179 | 71 | 4 | d3d3a9afaac28fa4f2c448c73d79bcbbbea088d7 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.95e-04 | 180 | 71 | 4 | c3d1521ac90f2e3fc31158e6e61907e05c37af39 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 180 | 71 | 4 | c54af6fb11484dacd3efa1f10a487376ff820a5e | |
| ToppCell | facs-Heart-RA-24m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 180 | 71 | 4 | 174c643e046646e3b305dd7e5b120d2c9a46690f | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 180 | 71 | 4 | 2405aa5699a8d8cf4c6b3dca07510e774728ac50 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 180 | 71 | 4 | 9c47852c0a723e2f5cd6898afff4c31a0da06905 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 180 | 71 | 4 | 499d5fe71e0dc20cffdf85e3b3f14eb4e83e3a3d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 180 | 71 | 4 | 07ac979b21be2425294d9818c48b5a1e6f014c19 | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.99e-04 | 181 | 71 | 4 | dff264815a3569f5666d0bbc3867c0496cd78774 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 182 | 71 | 4 | d41ff834b8fc1d0e23cac7ae261de5f72874e462 | |
| ToppCell | P28-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.04e-04 | 182 | 71 | 4 | db5d6c5e7d59734653906b126f2c1d57461a5290 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 182 | 71 | 4 | 6cde859edfe7607bd7ada89d20258413d06f4207 | |
| ToppCell | CF-Lymphoid-T_cell_&_NK_cell|CF / Disease state, Lineage and Cell class | 2.04e-04 | 182 | 71 | 4 | a8dfc59a3974e3433f434676b7c2749d0fcfc8b2 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 2.08e-04 | 183 | 71 | 4 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 183 | 71 | 4 | 1e51aeaa8fc9383b424cce128a890e07cb6025f3 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.12e-04 | 184 | 71 | 4 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.12e-04 | 184 | 71 | 4 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.12e-04 | 184 | 71 | 4 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | droplet-Thymus|droplet / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 185 | 71 | 4 | 83a78d17ad59503a694c1250082c4d8ae74d63e1 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 185 | 71 | 4 | a32d5cb596ebac80eb1ac301055e65d420879ec8 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 186 | 71 | 4 | 1e67bfb248366d7395efdd2d5e70a97bdb2e68af | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 186 | 71 | 4 | ba6ba75218efc26371cea24ddbb0e9b3e3f421ac | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 2.21e-04 | 186 | 71 | 4 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 186 | 71 | 4 | 65e25a9dcef5fc71510aaf170e220deef5b2feb2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.21e-04 | 186 | 71 | 4 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-04 | 186 | 71 | 4 | ffbc78058be8f0dc2e0335cc4c3195a636d17721 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-04 | 186 | 71 | 4 | ed924852cd7132c8f6703522037dc22bd2c83193 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 186 | 71 | 4 | e4f1259725160719e5fd13d76e5a707efed70013 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.26e-04 | 187 | 71 | 4 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 2.26e-04 | 187 | 71 | 4 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 187 | 71 | 4 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 187 | 71 | 4 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 187 | 71 | 4 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.31e-04 | 188 | 71 | 4 | 5bc1537e079c7435196c163bff5f639ea392a33a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-04 | 189 | 71 | 4 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-04 | 189 | 71 | 4 | 16e019fd6e2376110b767739754389891f391669 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 189 | 71 | 4 | 6f0fc5271a7d3682f145e734abc3be6473dda2e2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-04 | 189 | 71 | 4 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 189 | 71 | 4 | 3b9ce8964b16cb2200d30cbb0bfc711dcad2380e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 189 | 71 | 4 | 38acb307907fde68b992057714448c1561d69ee3 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.40e-04 | 190 | 71 | 4 | 3b9abc25b17e7295356ded57ff2ca519fa9f2686 | |
| ToppCell | facs-Heart-LA-24m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-04 | 190 | 71 | 4 | 911b93c4c828ef2d867b91a5eced2dc12a1baf27 | |
| ToppCell | PND01-03-samps-Endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.40e-04 | 190 | 71 | 4 | 1357bd4527399d7013ee33272bda7453f472999a | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.40e-04 | 190 | 71 | 4 | b4088128f5acf53f43244c9af9fe44e033f1a57a | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.40e-04 | 190 | 71 | 4 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.40e-04 | 190 | 71 | 4 | 5130fb325f80f591b9b36beacb8072c4472304f2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-04 | 190 | 71 | 4 | 078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-04 | 191 | 71 | 4 | 92b2faa72c184b6ae49530fd3b50848510904997 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.45e-04 | 191 | 71 | 4 | 3a5081dc542ac6262acfe5f8084a86616fee8082 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-04 | 191 | 71 | 4 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.45e-04 | 191 | 71 | 4 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-04 | 191 | 71 | 4 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 2.39e-06 | 196 | 70 | 7 | 6970_DN | |
| Drug | Lysergol [602-85-7]; Down 200; 15.8uM; PC3; HT_HG-U133A | 2.47e-06 | 197 | 70 | 7 | 6621_DN | |
| Drug | Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.06e-05 | 162 | 70 | 6 | 7340_UP | |
| Drug | retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A | 2.26e-05 | 185 | 70 | 6 | 6931_UP | |
| Drug | H-7 dihydrochloride; Down 200; 100uM; MCF7; HT_HG-U133A | 2.55e-05 | 189 | 70 | 6 | 5936_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 2.79e-05 | 192 | 70 | 6 | 5222_DN | |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.87e-05 | 193 | 70 | 6 | 4536_UP | |
| Drug | Prostaglandin E1; Down 200; 10uM; PC3; HT_HG-U133A | 2.95e-05 | 194 | 70 | 6 | 6555_DN | |
| Drug | Cholecalciferol [67-97-0]; Down 200; 10.4uM; PC3; HT_HG-U133A | 2.95e-05 | 194 | 70 | 6 | 6656_DN | |
| Drug | Halcinonide [3093-35-4]; Up 200; 8.8uM; PC3; HT_HG-U133A | 2.95e-05 | 194 | 70 | 6 | 7379_UP | |
| Drug | Esculetin [305-01-1]; Down 200; 22.4uM; HL60; HT_HG-U133A | 3.04e-05 | 195 | 70 | 6 | 3120_DN | |
| Drug | Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; PC3; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 7400_UP | |
| Drug | SB 202190; Up 200; 1uM; MCF7; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 7054_UP | |
| Drug | Oxaprozin [21256-18-8]; Down 200; 13.6uM; PC3; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 3794_DN | |
| Drug | Neostigmine bromide [114-80-7]; Up 200; 13.2uM; HL60; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 2432_UP | |
| Drug | Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 7325_DN | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; PC3; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 3756_DN | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Up 200; 12uM; PC3; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 6332_UP | |
| Drug | Trimipramine maleate salt [521-78-8]; Up 200; 9.8uM; HL60; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 3004_UP | |
| Drug | Ald1.1-H_000455; Down 200; 10uM; PC3; HT_HG-U133A | 3.40e-05 | 199 | 70 | 6 | 7547_DN | |
| Drug | Thioridazine hydrochloride [130-61-0]; Down 200; 9.8uM; PC3; HT_HG-U133A | 3.40e-05 | 199 | 70 | 6 | 4085_DN | |
| Drug | Trimethadione [127-48-0]; Down 200; 28uM; PC3; HT_HG-U133A | 3.50e-05 | 200 | 70 | 6 | 4086_DN | |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.35e-04 | 160 | 70 | 5 | 5275_UP | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A | 1.51e-04 | 164 | 70 | 5 | 3852_UP | |
| Drug | Digitoxigenin [143-62-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.56e-04 | 165 | 70 | 5 | 3275_UP | |
| Drug | Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 1.60e-04 | 166 | 70 | 5 | 5324_UP | |
| Drug | Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 1.60e-04 | 166 | 70 | 5 | 3283_UP | |
| Drug | retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A | 1.84e-04 | 171 | 70 | 5 | 5208_UP | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.89e-04 | 172 | 70 | 5 | 5903_DN | |
| Drug | retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A | 2.22e-04 | 178 | 70 | 5 | 1636_UP | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 2.27e-04 | 179 | 70 | 5 | 2656_UP | |
| Drug | lomustine; Down 200; 100uM; PC3; HT_HG-U133A | 2.33e-04 | 180 | 70 | 5 | 7094_DN | |
| Drug | staurosporine; Down 200; 1uM; MCF7; HG-U133A | 2.39e-04 | 181 | 70 | 5 | 312_DN | |
| Drug | retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A | 2.65e-04 | 185 | 70 | 5 | 6971_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A | 2.78e-04 | 187 | 70 | 5 | 2669_DN | |
| Drug | Ketoconazole [65277-42-1]; Up 200; 7.6uM; HL60; HT_HG-U133A | 2.92e-04 | 189 | 70 | 5 | 1285_UP | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | 3.07e-04 | 191 | 70 | 5 | 4454_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.07e-04 | 191 | 70 | 5 | 1057_DN | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; MCF7; HT_HG-U133A | 3.14e-04 | 192 | 70 | 5 | 5624_UP | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 3.14e-04 | 192 | 70 | 5 | 3753_DN | |
| Drug | rosiglitazone; Down 200; 10uM; PC3; HT_HG-U133A | 3.22e-04 | 193 | 70 | 5 | 1233_DN | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 7214_DN | |
| Drug | Leucomisine [17946-87-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 6767_DN | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 5599_DN | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 1uM; PC3; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 4291_DN | |
| Drug | Cefotiam hydrochloride; Down 200; 7.2uM; PC3; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 6762_DN | |
| Drug | Fursultiamine Hydrochloride [2105-43-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 4975_DN | |
| Drug | Gentamicine sulfate [1405-41-0]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 2245_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 2208_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 3766_DN | |
| Drug | Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; PC3; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 3699_DN | |
| Drug | Methoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; PC3; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 6627_DN | |
| Drug | Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; PC3; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 4083_DN | |
| Drug | Norfloxacin [70458-96-7]; Down 200; 12.6uM; PC3; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 2090_DN | |
| Drug | Practolol [6673-35-4]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 3204_UP | |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 3255_DN | |
| Drug | N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; PC3; HT_HG-U133A | 3.54e-04 | 197 | 70 | 5 | 6732_DN | |
| Drug | Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 3.54e-04 | 197 | 70 | 5 | 2888_UP | |
| Drug | genistein; Down 200; 10uM; PC3; HT_HG-U133A | 3.54e-04 | 197 | 70 | 5 | 4459_DN | |
| Drug | Tamoxifen citrate [54965-24-1]; Up 200; 7uM; HL60; HG-U133A | 3.54e-04 | 197 | 70 | 5 | 1366_UP | |
| Drug | Fosfosal [6064-83-1]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 3.54e-04 | 197 | 70 | 5 | 4823_DN | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; HL60; HG-U133A | 3.54e-04 | 197 | 70 | 5 | 1394_DN | |
| Drug | Mephenesin [59-47-2]; Down 200; 22uM; PC3; HT_HG-U133A | 3.54e-04 | 197 | 70 | 5 | 7374_DN | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; PC3; HT_HG-U133A | 3.54e-04 | 197 | 70 | 5 | 5076_UP | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A | 3.54e-04 | 197 | 70 | 5 | 3781_DN | |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; HL60; HT_HG-U133A | 3.54e-04 | 197 | 70 | 5 | 2557_DN | |
| Drug | Flucloxacillin sodium [1847-24-1]; Up 200; 8.4uM; PC3; HT_HG-U133A | 3.62e-04 | 198 | 70 | 5 | 5102_UP | |
| Drug | Dequalinium dichloride [522-51-0]; Up 200; 7.6uM; PC3; HT_HG-U133A | 3.62e-04 | 198 | 70 | 5 | 6296_UP | |
| Drug | Theobromine [83-67-0]; Down 200; 22.2uM; MCF7; HT_HG-U133A | 3.62e-04 | 198 | 70 | 5 | 4958_DN | |
| Drug | Mesoridazine besylate [32672-69-8]; Up 200; 7.4uM; PC3; HT_HG-U133A | 3.62e-04 | 198 | 70 | 5 | 7256_UP | |
| Drug | Glycopyrrolate [596-51-0]; Down 200; 10uM; PC3; HT_HG-U133A | 3.62e-04 | 198 | 70 | 5 | 3687_DN | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 3.62e-04 | 198 | 70 | 5 | 6073_DN | |
| Drug | Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; PC3; HT_HG-U133A | 3.62e-04 | 198 | 70 | 5 | 5099_DN | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 3.62e-04 | 198 | 70 | 5 | 3764_DN | |
| Drug | Fusaric acid [536-69-6]; Down 200; 22.4uM; PC3; HT_HG-U133A | 3.62e-04 | 198 | 70 | 5 | 3986_DN | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 1uM; PC3; HT_HG-U133A | 3.62e-04 | 198 | 70 | 5 | 7391_UP | |
| Drug | Methacycline hydrochloride [3963-95-9]; Down 200; 8.4uM; PC3; HT_HG-U133A | 3.62e-04 | 198 | 70 | 5 | 4062_DN | |
| Drug | Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.70e-04 | 199 | 70 | 5 | 7192_DN | |
| Drug | carmustine; Down 200; 100uM; MCF7; HT_HG-U133A | 3.70e-04 | 199 | 70 | 5 | 6888_DN | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 3.70e-04 | 199 | 70 | 5 | 5931_UP | |
| Drug | Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; PC3; HT_HG-U133A | 3.70e-04 | 199 | 70 | 5 | 4013_DN | |
| Drug | Amoxicillin [26787-78-0]; Up 200; 11uM; PC3; HT_HG-U133A | 3.70e-04 | 199 | 70 | 5 | 6285_UP | |
| Drug | Glimepiride [93479-97-1]; Down 200; 8.2uM; PC3; HT_HG-U133A | 3.79e-04 | 200 | 70 | 5 | 6628_DN | |
| Drug | Tobramycin [32986-56-4]; Up 200; 8.6uM; HL60; HT_HG-U133A | 3.79e-04 | 200 | 70 | 5 | 2481_UP | |
| Drug | Piracetam [7491-74-9]; Down 200; 28.2uM; PC3; HT_HG-U133A | 3.79e-04 | 200 | 70 | 5 | 5043_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 3.79e-04 | 200 | 70 | 5 | 2323_DN | |
| Drug | Ramipril [87333-19-5]; Up 200; 9.6uM; HL60; HT_HG-U133A | 3.79e-04 | 200 | 70 | 5 | 6150_UP | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; PC3; HT_HG-U133A | 3.79e-04 | 200 | 70 | 5 | 4489_DN | |
| Drug | Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 3.79e-04 | 200 | 70 | 5 | 3222_UP | |
| Disease | Hodgkins lymphoma | 4.42e-05 | 82 | 70 | 4 | EFO_0000183 | |
| Disease | valine measurement | 1.19e-04 | 40 | 70 | 3 | EFO_0009792 | |
| Disease | R-6-hydroxywarfarin measurement | 1.59e-04 | 114 | 70 | 4 | EFO_0803327 | |
| Disease | apolipoprotein A 1 measurement | 1.74e-04 | 848 | 70 | 9 | EFO_0004614 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 40 | 1.98e-04 | 9 | 70 | 2 | C4225275 | |
| Disease | cancer antigen 125 measurement | 2.47e-04 | 10 | 70 | 2 | EFO_0010603 | |
| Disease | gluteofemoral adipose tissue measurement | 2.79e-04 | 132 | 70 | 4 | EFO_0803317 | |
| Disease | Metastatic melanoma | 2.91e-04 | 54 | 70 | 3 | C0278883 | |
| Disease | nucleus accumbens volume change measurement | 3.01e-04 | 11 | 70 | 2 | EFO_0021493 | |
| Disease | insulin measurement | 4.38e-04 | 267 | 70 | 5 | EFO_0004467 | |
| Disease | leptin measurement, type 2 diabetes mellitus | 6.52e-04 | 16 | 70 | 2 | EFO_0005000, MONDO_0005148 | |
| Disease | body fat percentage, type 2 diabetes mellitus | 7.37e-04 | 17 | 70 | 2 | EFO_0007800, MONDO_0005148 | |
| Disease | cardiovascular disease | 7.58e-04 | 457 | 70 | 6 | EFO_0000319 | |
| Disease | triglyceride measurement, body fat percentage | 1.13e-03 | 21 | 70 | 2 | EFO_0004530, EFO_0007800 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 1.48e-03 | 206 | 70 | 4 | EFO_0004612, EFO_0020947 | |
| Disease | body fat percentage, high density lipoprotein cholesterol measurement | 1.61e-03 | 25 | 70 | 2 | EFO_0004612, EFO_0007800 | |
| Disease | BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment | 2.02e-03 | 105 | 70 | 3 | EFO_0007788, EFO_0008007, EFO_0008343 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HPAALGHGPLSSLSP | 276 | Q9Y2J4 | |
| LSPHGPGPHLSTSHL | 351 | Q9HCM7 | |
| PSTVPLPHSSGIHGI | 1321 | Q9P281 | |
| HAVPPQHTLGSVPGS | 321 | O95196 | |
| GRLPSLVHGPSHPDS | 121 | P59052 | |
| PETLTHTASPHPGGA | 581 | Q92625 | |
| TGHPGIIPPHATLVF | 86 | P62942 | |
| VHPGVTVHPPPSTGL | 271 | O95980 | |
| DHGTPPLSTESHIPL | 426 | Q9Y5G8 | |
| HPALPTHPGHTFISG | 426 | Q96N11 | |
| PGPHTTGIPHPAIVT | 251 | Q9UJU2 | |
| VPEGAPSVHHPLLTS | 76 | Q9UBU8 | |
| LHPSSSVPVGLPTGR | 731 | Q8N1W1 | |
| IHSQPSGHTPPKVTG | 6031 | Q8WXI7 | |
| RHSSSPLSPGGPTHL | 1771 | Q9Y618 | |
| AAVTTPVTPAGHGHP | 26 | Q9H4G0 | |
| THLAPLPSPHVGAAS | 446 | A6NCF5 | |
| PVTVKSPVLPSGHHL | 171 | Q5T3J3 | |
| ITGHHVPDSGPEPIL | 461 | Q8NE63 | |
| TSFPAHPSLLLHGPS | 351 | P26006 | |
| HEPVGSGTLISHPLP | 1071 | Q9HC56 | |
| VTHLPSPHPKTNISG | 356 | A0A1B0GTH6 | |
| PGSTRGKVHPLTSHP | 601 | Q5T7B8 | |
| GSHVEVTPHTAPPGV | 1616 | P50851 | |
| HGVHGPPALSGSPVI | 81 | P10070 | |
| PAHGTRGPPSTTHQV | 601 | Q96KJ4 | |
| AGASPSTLPSHVPGH | 376 | Q9P242 | |
| HPPISPHFGTTTVIS | 796 | Q02413 | |
| GSPTHGLPARSPTHS | 1126 | Q9Y2H9 | |
| TGSHLVTVPPGPSLA | 651 | A2A3N6 | |
| GLVITTHHPAPSAAP | 506 | Q9HAP2 | |
| GHLPPFSHSGHILPT | 441 | P23769 | |
| PFSKTSIHHGSPGPL | 116 | P23771 | |
| THGPFTTCPGSHPVL | 221 | Q8IXT2 | |
| PGTLEISPHHSFGLP | 2346 | Q9H799 | |
| TPVPLSGLIHIIGHP | 461 | Q96PZ2 | |
| PPSTPITVTGHGLAV | 41 | Q9H972 | |
| PVSLSSPGTPGTQHH | 16 | P10075 | |
| SSGGTPLHSPLHTPR | 511 | Q8TDC3 | |
| VSVVPGISGHPEPRH | 191 | P31276 | |
| HAHAPGTAPPPVVST | 56 | Q8N539 | |
| PTIGSLRIHPHPGAD | 71 | A6PVL3 | |
| PHLPGLFGSSTLSPH | 1021 | Q14147 | |
| TGSHLVTVPPGPSLA | 166 | P55036 | |
| VGTVSADTPPPHHGL | 481 | P20264 | |
| RPGSPHLPHTSLGEA | 1196 | O94851 | |
| GIGPSLTPGAPHHLS | 376 | Q99487 | |
| LHVGATPSPLLHGPA | 86 | Q96NZ1 | |
| IPPPNVTGSLHLGHA | 341 | P26640 | |
| PGSTLTPPAVGLVHS | 501 | P07204 | |
| HVGLPLAPGTHSAPT | 556 | O75157 | |
| PATTLPVPSLGNHHT | 626 | Q9NP60 | |
| PPRSEGSHHITSTPG | 56 | O43166 | |
| HLHIGTGPTALPAVP | 731 | A0A0B4J2F2 | |
| HLHIGTGPTALPAVP | 731 | P57059 | |
| DLPHTQGALTSPGHP | 131 | Q3SY56 | |
| PSTGVPHSLVHNTLP | 306 | Q9UPG8 | |
| ISSGHVPHGPLTRPS | 476 | O95793 | |
| IHSNGTPIHTPTPTP | 841 | Q2KHR2 | |
| LDPTHNPGTPGLHTS | 811 | Q8NF64 | |
| TGIPVSPTHHPVGTG | 341 | Q6ZNC4 | |
| PGSPGTLALRSPHHA | 581 | Q96F45 | |
| GPHTSPSHTLGKASP | 466 | Q8N5H7 | |
| PVSPGHSTAVVSLPG | 361 | Q8TEC5 | |
| THIGGPHVATSVPLP | 1061 | Q5SXM2 | |
| VPSPGTVHTALLHPT | 61 | P0C7M3 | |
| IPGTSPLPAHGSHLD | 1106 | Q9H7P9 | |
| PSVSALTPHAGTGPV | 241 | Q15906 | |
| RPATLDTAHPHGGPS | 241 | Q6DKI7 | |
| PRAEGHPPTHTISTI | 86 | Q6UXF1 | |
| LPDSPGSHLPHTVTL | 151 | P53667 | |
| ISAGPGSVSPHLHVP | 266 | P28698 | |
| YHSPELTTPPGHGTL | 211 | Q96NK8 |